2025
Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians
Elliott S, B Katz R, B Ostroff R, Ansari M, Holmes S, Sanacora G. Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians. FOCUS The Journal Of Lifelong Learning In Psychiatry 2025, 23: 195-205. PMID: 40235610, PMCID: PMC11995899, DOI: 10.1176/appi.focus.20240040.Peer-Reviewed Original ResearchTreatment-resistant depressionElectroconvulsive therapyCases of treatment-resistant depressionTreatment of depressionEfficacy of ketamineDepressive disorderSevere casesDepressionPatient selection criteriaPatient-specific factorsOptimal treatment choicePatient-specific considerationsKetamineStudy outcome measuresTreatment deliveryBenefit profileMeta-analysesTreatment choiceNoninferiority trialPublic health challengeEffective treatmentOutcome measuresGold standardUnique risksTherapy
2019
Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations
Siddique S, Gada H, Mumtaz M, Vora A. Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations. Current Cardiology Reports 2019, 21: 161. PMID: 31781976, DOI: 10.1007/s11886-019-1250-5.Peer-Reviewed Original ResearchConceptsLow-risk patientsComposite endpoint of deathEndpoint of deathOptimal treatment choiceRandomized studyComposite endpointNon-inferior to surgeryTreatment choiceLow surgical risk patientsSurgical risk patientsPARTNER 3 trialSymptomatic aortic stenosisSymptomatic ASLack of long-term dataAortic stenosisFDA indicationRisk patientsPacemaker implantationValve deteriorationAnatomical factorsSummaryRecent trialsTAVRPatientsHigher incidenceProcedural considerations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply